Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$524K Buy
34,042
+15,463
+83% +$257K ﹤0.01% 3306
2025
Q4
$335K Sell
18,579
-13,077
-41% -$225K ﹤0.01% 3511
2025
Q3
$510K Buy
31,656
+17,053
+117% +$249K ﹤0.01% 3218
2025
Q2
$159K Sell
14,603
-457
-3% -$5.12K ﹤0.01% 4047
2025
Q1
$188K Buy
+15,060
New +$248K ﹤0.01% 4035
2021
Q2
Sell
-7,409
Closed -$123K 3509
2021
Q1
$123K Buy
+7,409
New +$140K ﹤0.01% 2854

Other funds holding MESO

Squarepoint's MESO Position: Q1 2026 in Review

Squarepoint increased its Mesoblast (MESO) stake by 83% in Q1 2026, buying an estimated $257K and bringing the position to 34,042 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #3306.

Squarepoint first reported a position in MESO in Q1 2021 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Squarepoint held 34,042 shares of Mesoblast worth $524K as of Q1 2026.
  • Squarepoint bought 15,463 Mesoblast shares in Q1 2026, an estimated $257K.
  • Mesoblast made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3306 holding.
  • Squarepoint first reported a position in Mesoblast in Q1 2021 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.